Cargando…

Risk Factors for Tigecycline-Associated Hypofibrinogenemia

BACKGROUND: With the widespread use of tigecycline, especially in elderly people infected with multidrug-resistant bacteria, the associated coagulation disorders are attracting the attention of clinicians. The risk factors of tigecycline-associated hypofibrinogenemia are still controversial. PURPOSE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jia, Yan, Yingying, Zhang, Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057826/ https://www.ncbi.nlm.nih.gov/pubmed/33888987 http://dx.doi.org/10.2147/TCRM.S302850

Ejemplares similares

Incidence, characteristics and risk factors of hypofibrinogenemia associated with tigecycline: A multicenter retrospective study in China
por: Leng, Bing, et al.
Publicado: (2022)

Tigecycline-associated hypofibrinogenemia: A case report and review of the literature
por: Wu, Pei-Chun, et al.
Publicado: (2018)

Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
por: Zhang, Lei, et al.
Publicado: (2023)

A Lesser Known Side Effect of Tigecycline: Hypofibrinogenemia
por: Yılmaz Duran, Fulya, et al.
Publicado: (2018)

Hypofibrinogenemia induced by high-dose tigecycline—case report and review of literature
por: Fan, Qiaomei, et al.
Publicado: (2020)

Spontaneous Knee Hemarthrosis Due to Hypofibrinogenemia Following Tigecycline Treatment for Periprosthetic Joint Infection
por: Balfousias, Theodore, et al.
Publicado: (2019)

A case report of patient with severe acute cholangitis with tigecycline treatment causing coagulopathy and hypofibrinogenemia
por: Wu, Xiaoqin, et al.
Publicado: (2017)

Transient hypofibrinogenemia due to allopurinol
por: Yin, ZhiQiang, et al.
Publicado: (2014)

Early Predictive Factors of Hypofibrinogenemia in Acute Trauma Patients
por: Paydar, Shahram, et al.
Publicado: (2018)

Risk factors and clinical outcomes associated with acquired hypofibrinogenemia in patients administered hemocoagulase batroxobin for hemoptysis
por: Lee, Jae-Kyeong, et al.
Publicado: (2022)

Acquired hypofibrinogenemia: current perspectives
por: Besser, Martin W, et al.
Publicado: (2016)

Hereditary Hypofibrinogenemia with Hepatic Storage
por: Asselta, Rosanna, et al.
Publicado: (2020)

Clinical Manifestations and Risk Factors of Tigecycline-Associated Thrombocytopenia
por: Zhu, Yuanchao, et al.
Publicado: (2023)

Early Predictive Factors of Hypofibrinogenemia in Acute Trauma Patients
por: Radjou, Angeline Neetha
Publicado: (2018)

Congenital hypofibrinogenemia in pregnancy: a report of 11 cases
por: Cai, He, et al.
Publicado: (2018)

Women With Congenital Hypofibrinogenemia/Afibrinogenemia: From Birth to Death
por: Zhang, Yan, et al.
Publicado: (2020)

Risk factors with the development of infection with tigecycline- and carbapenem-resistant Enterobacter cloacae
por: Jiang, Yuansu, et al.
Publicado: (2019)

Fibrinogen storage disease without hypofibrinogenemia associated with estrogen therapy
por: Simsek, Z, et al.
Publicado: (2005)

1430. Eravacycline associated hypofibrinogenemia during treatment of M.abscessus
por: Rausch, Ethan, et al.
Publicado: (2022)

Total knee arthroplasty in a patient with hypofibrinogenemia
por: Nacca, Christopher R., et al.
Publicado: (2015)

Loss of Fibrinogen in Zebrafish Results in Symptoms Consistent with Human Hypofibrinogenemia
por: Vo, Andy H., et al.
Publicado: (2013)

Hypofibrinogenemia Caused by Hemocoagulase After Colon Polyps Excision
por: Zhou, Hai-Bo
Publicado: (2017)

Congenital Hypofibrinogenemia: Presentation of a Rare Coagulation Disorder
por: Acevedo Viales, Karol, et al.
Publicado: (2020)

Hypofibrinogenemia is an independent predictor of hemophagocytic lymphohistiocytosis in children with sepsis
por: Luo, Xin, et al.
Publicado: (2023)

Fulfillment status of hypertriglyceridemia and hypofibrinogenemia in children with hemophagocytic lymphohistiocytosis and risks of multiple organ dysfunction syndrome and early mortality
por: Li, Xun, et al.
Publicado: (2022)

Clinical Characteristics of Hospitalized Neonates With Hypofibrinogenemia: A Retrospective Cohort Study
por: Zhou, Weijun, et al.
Publicado: (2020)

Anesthetic Management of an Adolescent with Hypofibrinogenemia Posted for Cervical Deformity Correction!
por: Tyagi, Mayank, et al.
Publicado: (2020)

Preeclampsia complicated with hypofibrinogenemia: 2 case reports and review of the literature
por: Li, Shiguang, et al.
Publicado: (2023)

IMPACT OF THE INTRAOPERATIVE USE OF FIBRINOGEN CONCENTRATE FOR HYPOFIBRINOGENEMIA DURING THORACIC AORTIC SURGERY
por: ARAKI, YOSHIMORI, et al.
Publicado: (2015)

Raising the bar on fibrinogen: a retrospective assessment of critical hypofibrinogenemia in severely injured trauma patients
por: Richards, Justin, et al.
Publicado: (2023)

Hypofibrinogenemia following injury in 186 children and adolescents: identification of the phenotype, current outcomes, and potential for intervention
por: Gerard, Justin, et al.
Publicado: (2023)

Case Report: Life-Threatening Post-operative Hemorrhage in Klippel–Trenaunay Syndrome Associated With Hypofibrinogenemia
por: Yang, Hongna, et al.
Publicado: (2021)

Congenital Hypofibrinogenemia in a Neonate with a Novel Mutation in the FGB Gene
por: Shinozuka, Jun, et al.
Publicado: (2021)

Acute myocardial infarction in a patient with hypofibrinogenemia: a case report
por: Mghaieth, Fathia, et al.
Publicado: (2011)

Prenatal and Peripartum Management of Patients with Hypofibrinogenemia Resulted in Two Successful Deliveries
por: Teraoka, Yuko, et al.
Publicado: (2017)

Angiosarcoma of the breast with hypofibrinogenemia: A rare case report and review of the literature
por: An, Ran, et al.
Publicado: (2022)

Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
por: He, Tingyan, et al.
Publicado: (2023)

Emergence of tigecycline resistance in Escherichia coli co-producing MCR-1 and NDM-5 during tigecycline salvage treatment
por: Wang, Qian, et al.
Publicado: (2018)

Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients
por: Hu, Juan, et al.
Publicado: (2020)

Heterogeneity of Genotype–Phenotype in Congenital Hypofibrinogenemia—A Review of Case Reports Associated with Bleeding and Thrombosis
por: Brunclikova, Monika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fb8akmt45vp4milnhbnbpbbdan